A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/27507905/ below:

A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening

Randomized Controlled Trial

. 2017 Nov;66(11):1975-1982. doi: 10.1136/gutjnl-2016-311819. Epub 2016 Aug 9. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening M van der Vlugt  2 A J van Vuuren  1 A K Stroobants  3 M W Mundt  4 W J Spijker  5 E J C Bongers  6 E J Kuipers  1 I Lansdorp-Vogelaar  7 P M Bossuyt  8 E Dekker  2 M C W Spaander  1

Affiliations

Affiliations

Item in Clipboard

Randomized Controlled Trial

A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening

E J Grobbee et al. Gut. 2017 Nov.

. 2017 Nov;66(11):1975-1982. doi: 10.1136/gutjnl-2016-311819. Epub 2016 Aug 9. Authors E J Grobbee  1 M van der Vlugt  2 A J van Vuuren  1 A K Stroobants  3 M W Mundt  4 W J Spijker  5 E J C Bongers  6 E J Kuipers  1 I Lansdorp-Vogelaar  7 P M Bossuyt  8 E Dekker  2 M C W Spaander  1 Affiliations

Item in Clipboard

Abstract

Objective: Colorectal cancer screening programmes are implemented worldwide; many are based on faecal immunochemical testing (FIT). The aim of this study was to evaluate two frequently used FITs on participation, usability, positivity rate and diagnostic yield in population-based FIT screening.

Design: Comparison of two FITs was performed in a fourth round population-based FIT-screening cohort. Randomly selected individuals aged 50-74 were invited for FIT screening and were randomly allocated to receive an OC -Sensor (Eiken, Japan) or faecal occult blood (FOB)-Gold (Sentinel, Italy) test (March-December 2014). A cut-off of 10 µg haemoglobin (Hb)/g faeces (ie, 50 ng Hb/mL buffer for OC-Sensor and 59 ng Hb for FOB-Gold) was used for both FITs.

Results: In total, 19 291 eligible invitees were included (median age 61, IQR 57-67; 48% males): 9669 invitees received OC-Sensor and 9622 FOB-Gold; both tests were returned by 63% of invitees (p=0.96). Tests were non-analysable in 0.7% of participants using OC-Sensor vs 2.0% using FOB-Gold (p<0.001). Positivity rate was 7.9% for OC-Sensor, and 6.5% for FOB-Gold (p=0.002). There was no significant difference in diagnostic yield of advanced neoplasia (1.4% for OC-Sensor vs 1.2% for FOB-Gold; p=0.15) or positive predictive value (PPV; 31% vs 32%; p=0.80). When comparing both tests at the same positivity rate instead of cut-off, they yielded similar PPV and detection rates.

Conclusions: The OC-Sensor and FOB-Gold were equally acceptable to a screening population. However, FOB-Gold was prone to more non-analysable tests. Comparison between FIT brands is usually done at the same Hb stool concentration. Our findings imply that for a fair comparison on diagnostic yield between FIT's positivity rate rather than Hb concentration should be used.

Trial registration number: NTR5385; Results.

Keywords: COLORECTAL CANCER SCREENING; COLORECTAL CARCINOMA.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

PubMed Disclaimer

Similar articles Cited by

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3